CompanyArdan Equity, Phreesia, Humedica

Skills & ExpertiseB2B, Board Roles, Building a Team, Co-Founder Dynamics, Company Culture, Customer Acquisition, Fundraising Strategies, Go-To-Market Strategy, Marketing, Market Research, MVP Development, Pitch Feedback, Product Roadmap, Scaling, Social Impact, Strategic Partnerships

Industry Digital Health; Healthcare; Venture Capital

Michael Weintraub (MBA 1988) is Co-Founder and Managing Partner of Ardan Equity Partners, a healthcare enterprise software private equity firm. Weintraub is Founding Chairman of Phreesia (NYSE: PHR).

Previously, Michael was Co-Founder and Managing Partner of Optum Ventures, focused on digital health innovation. Weintraub was Co-Founder and CEO of Humedica, a pioneer and leader in the the field of population health management and big data. Following Humedica's acquisition by UnitedHealth Group (UHG), Michael broadened his role within UHG as President and CEO of Optum Analytics. Prior to launching Humedica, Weintraub was a Senior Managing Director at Leerink Partners (now SVB Leerink), a leading healthcare investment bank. Michael also was CEO of PharMetrics, a health care informatics company, which was acquired by IMS Health (now IQVIA).

Weintraub currently serves as Chairman of BroadReach Healthcare, a global healthcare company based in Cape Town, South Africa. Michael serves as Chairman of Holmusk, a Behavioral Health Real World Evidence company. Weintraub is a member of the board of directors of Centene (Health Care Enterprises), CorEvitas, Oncology Analytics, Panalgo, NewFire Partners, and The College Diabetes Network (CDN). Michael also focuses on healthcare innovation as an Entrepreneur in Residence at Harvard Business School, and an Advisory Board member of the Innovation and Digital Health Accelerator at Boston Children’s Hospital. Weintraub received his Bachelor’s Degree in Economics from Brandeis University and an MBA from Harvard Business School.